Development, Safety, Issues, and Challenges of the SARS-CoV-2 Vaccine

Vaccines (Basel). 2023 Mar 1;11(3):569. doi: 10.3390/vaccines11030569.

Abstract

It has been reported that some mutant strains of the new coronavirus escape from neutralizing antibodies acquired by recoverees and vaccine recipients, in which the Omicron strain (B [...].

Publication types

  • Editorial